Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Lymphoma 7Breast Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Acute 5Multiple Myeloma 4Lymphoma, T-Cell, Cutaneous 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Leukemia 3Glioblastoma 3Brain Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Recurrence 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Oligodendroglioma 2Neoplasms 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2

Interventions

pazopanib 2Trabectedin 2Doxorubicin 2sapanisertib 1rucaparib 1pembrolizumab 1itacitinib 1baricitinib 1avelumab 1Vorinostat 1TTI-621 1PTC596 1Letrozole 1Ifosfamide 1INCB039110 1Docetaxel 1Dacarbazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leiomyosarcoma × Vorinostat × Clear all
NCT03509207 2020-08-04

Vorinostat (SAHA) in Uterine Sarcoma

Medical University of Graz

Phase 2 Terminated
3 enrolled 6 charts
GynecologicSarcoma

Leiomyosarcoma, Endometrial Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡